Cargando…

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

As increased angiogenesis has been linked with the progression of ovarian cancer, a number of anti-angiogenic agents have been investigated, or are currently in development, as potential treatment options for patients with advanced disease. Bevacizumab, a recombinant monoclonal antibody against vasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Aravantinos, Gerasimos, Pectasides, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033616/
https://www.ncbi.nlm.nih.gov/pubmed/24864163
http://dx.doi.org/10.1186/1757-2215-7-57